In clinical trials, an LCHFD induced weight loss and decreased blood glucose levels, steatosis, and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in patients with obesity [30,31,32,33,34]. The gene discussed is GPT; the disease is steatosis.